英文别名 |
Cediranib;4-(4-Fluoro-2-methylindol-5-yloxy)-6-methoxy-7-[3-(pyrrolidin-1-yl)propoxy]quinazoline;Cediranib (AZD217);Cediranib (AZD2171);Cediranib (AZD2171, Recentin®);cedirannib;Quinazoline, 4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-6-methoxy-7-[3-(1-pyrrolidinyl)propoxy]-;AZD2171;AZD-2171;Recentin;AZD 2171;4-((4-Fluoro-2-methyl-1H-indol-5-yl)oxy)-6-methoxy-7-(3-(pyrrolidin-1-yl)propoxy)quinazoline;NQU9IPY4K9;4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-6-methoxy-7-[3-(pyrrolidin-1-yl)propoxy]quinazoline;C25H27FN4O3;Cediranib (USAN/INN);Cediranib [USAN:INN;DTXSID10183035;FT-0751000;AZD2171, Cediranib;Q5057052;GTPL5664;XXJWYDDUDKYVKI-UHFFFAOYSA-N;D08881;4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-6-methoxy-7-(3-pyrrolidin-1-ylpropoxy)quinazoline;s1017;AV3;Cediranib [INN];HY-10205;AKOS005145767;SCHEMBL63147;SMR004701223;EX-A2039;CS-0119;4-((4-FLUORO-2-METHYL-1H-INDOL-5-YL)OXY)-6-METHOXY-7-(3-PYRROLIDIN-1-YLPROPOXY)QUINAZOLINE;CCG-264679;HMS3674G17;4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-6-methoxy-7-(3-(pyrrolidin-1-yl)propoxy)quinazoline;CEDIRANIB [MART.];BCPP000295;Q-101399;NSC755606;DB04849;NSC-800069;BCP9000500;AMY16021;AC-25033;MFCD09954115;Quinazoline, 4-((4-fluoro-2-methyl-1H-indol-5-yl)oxy)-6-methoxy-7-(3-(1-pyrrolidinyl)propoxy)-;ZD 2171;288383-20-0;NSC-732208;CEDIRANIB [WHO-DD];MLS006010063;NSC-755606;BCP01378;4-(4-fluoro-2-methylindol-5-yloxy)-6-methoxy-7-(3-(pyrrolidin-1-yl)propoxy)quinazoline;Quinazoline,4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-6-methoxy-7-[3-(1-pyrrolidinyl)propoxy]-;NCGC00263097-09;HMS3744O21;HMS3654G05;SB16536;UNII-NQU9IPY4K9;Cediranib,AZD2171;NS00069640;Cediranib free base;CHEMBL491473;BRD-K86930074-001-01-9;NCGC00263097-01;CHEBI:94782;288383-20-0 (free base);Kinome_3318;ES-0052;A24280;BDBM50331096;4-(4-Fluoro-2-methyl-1H-indol-5-yloxy)-6-methoxy-7-(3-pyrrolidin-1-yl-propoxy)-quinazoline;NSC800069;SW219261-1;Cediranib [USAN:INN:BAN];ZD-2171;CEDIRANIB [USAN];Cediranib?;4-[(4-Fluoro-2-methyl-1H-indol-5-yl)oxy]-6-methoxy-7-[3-(pyrrolidin-1-yl)propoxy]quinazoline; 4-[(4-Fluoro-2-methyl-1H-indol-5-yl)oxy]-6-methoxy-7-[3-(1-pyrrolidinyl)propoxy]quinazoline; 4-(4-Fluoro-2-methylindol-5-yloxy)-6-methoxy-7-[3-(pyrrolidin-1-yl)propoxy]quinazoline; ZD 2171; AZD 2171;BRD-K86930074-001-05-0;GLXC-02838;SDCCGSBI-0654326.P001 |